What Are the Pregnancy Risks for Women With ADPKD?
At a Glance
Women with ADPKD can often have successful pregnancies, but risk is higher with reduced kidney function, high blood pressure, or protein in the urine. Preconception medication review and close monitoring help identify pre-eclampsia and other complications early.
For many women with Autosomal Dominant Polycystic Kidney Disease (ADPKD), it is entirely possible to have a safe and successful pregnancy. However, because ADPKD affects kidney function and blood pressure, pregnancy requires careful individualized planning. Rather than assuming all ADPKD pregnancies are identical, doctors assess your specific risk based on your baseline kidney health before conception [1][2].
Before Trying: Assessing Your Individual Risk
Your personal risk level during pregnancy depends heavily on three factors before you conceive: your kidney function, your blood pressure, and the amount of protein in your urine (proteinuria) [1][3].
- Favorable Outlook: Women with preserved kidney function, controlled blood pressure, and little or no proteinuria generally have lower risks of complications [1][2].
- Higher Risk: Women with reduced kidney function (chronic kidney disease or CKD), substantial proteinuria, uncontrolled high blood pressure, prior preterm birth, or a history of pre-eclampsia require more intensive co-management [2][3]. If you have a family history of intracranial aneurysms (blood vessel bulges in the brain), your doctor may also review this before pregnancy.
Medication Planning: Managing blood pressure is critical, but some common medications like ACE inhibitors and ARBs are contraindicated (unsafe) during pregnancy because of fetal safety concerns, and must be replaced with pregnancy-safe alternatives [4]. Additionally, tolvaptan, a drug used to slow ADPKD progression, should not be used during pregnancy [5]. Do not stop or change these medications on your own. You should establish a written medication plan with your nephrologist (kidney doctor) well before stopping birth control to safely transition your treatments [4][5].
During Pregnancy: Monitoring and Risks
Your care should involve a collaborative team, including your nephrologist and a Maternal-Fetal Medicine (MFM) specialist (an obstetrician specializing in high-risk pregnancies) [1][5].
How Your Kidneys Are Monitored: Before pregnancy, doctors use a calculation called “eGFR” to estimate your kidney function. However, standard eGFR equations are not reliable during pregnancy. Instead, your care team will track trends in your serum creatinine (a blood marker), blood pressure, and quantitative urine protein [1][6]. While some limited evidence suggests pregnancy hormones might temporarily increase kidney cyst growth, the long-term impact of this on ADPKD progression is uncertain [2][1].
Pre-Eclampsia and Aspirin Prophylaxis: Women with ADPKD have a higher risk of developing pre-eclampsia [7]. Pre-eclampsia is a serious condition diagnosed after 20 weeks of pregnancy, involving new high blood pressure along with protein in the urine or signs of damage to other organs. Because having CKD increases this risk, many medical guidelines recommend asking your doctor if low-dose aspirin is appropriate for you (often started between 12 to 16 weeks) to help reduce pre-eclampsia risk [5]. Do not start taking aspirin without your doctor’s guidance.
Urgent Warning Signs of Pre-Eclampsia
Pre-eclampsia can develop gradually, and pre-existing ADPKD symptoms can sometimes make it difficult to recognize. Seek urgent medical care if you experience:
- Severe or persistent headache
- Visual changes (blurriness, seeing spots)
- Right upper abdominal pain (under the ribs)
- Shortness of breath
- Markedly elevated blood pressure readings
- Rapidly increasing swelling (mild swelling is normal in pregnancy, but sudden or severe edema requires prompt evaluation)
Risks to the Baby: A Mayo Clinic study comparing pregnancies in 54 women with ADPKD to 92 women with simple kidney cysts found that miscarriage rates were similar between the groups [7]. However, premature birth (delivering before 37 weeks) occurred in 11.1% of the ADPKD group compared to 6.8% in the simple cyst group, and nonreassuring fetal status (previously called “fetal distress”) was also significantly more common [7]. These risks underscore the need for regular fetal growth ultrasounds throughout your pregnancy [1].
After Delivery: Postpartum Care
Care does not end at delivery. Pregnancy can sometimes be followed by changes in kidney function, and pre-eclampsia can even develop in the postpartum period [1][7]. Ensure you have a scheduled postpartum review of your blood pressure, serum creatinine, and urine protein [1]. You will also need to discuss with your doctor which blood pressure medications are safe for breastfeeding and when it is appropriate to resume ADPKD-specific therapies like tolvaptan [5].
Family Planning and Inheritance
ADPKD is an autosomal dominant condition, meaning that if one parent carries the genetic variant, each child has a 50% chance of inheriting it, regardless of the child’s sex [8][9]. Inheriting the variant means the child will likely develop ADPKD, but it does not predict exactly when symptoms will appear or how severe the disease will be.
Decisions about family planning are deeply personal, and there is no single “right” reproductive choice. If you wish to understand or reduce the risk of passing on the condition, you have several options:
- PGT-M (Preimplantation Genetic Testing for Monogenic conditions): This uses In Vitro Fertilization (IVF) to test embryos and select ones without your familial ADPKD variant for transfer [10][11]. While effective, PGT-M is not guaranteed to result in a pregnancy or an unaffected child, it requires your family’s specific mutation to be identified beforehand, and it involves the financial and physical demands of IVF [12][10]. Confirmatory prenatal testing during the pregnancy is still sometimes offered.
- Natural Conception with Prenatal Diagnosis: Conceiving naturally and testing the fetus during pregnancy (via chorionic villus sampling or amniocentesis) [10].
- Other Options: Using donor eggs or donor sperm, adoption, or choosing not to pursue pregnancy. Discussing these options with a genetic counselor can help you make an informed decision that aligns with your family’s goals.
Common questions in this guide
Can I have a healthy pregnancy if I have ADPKD?
What complications are more likely during pregnancy with ADPKD?
How are my kidneys monitored while I am pregnant with ADPKD?
Do ADPKD medications need to change before pregnancy?
Should I take low-dose aspirin to prevent pre-eclampsia with ADPKD?
What symptoms need urgent attention during an ADPKD pregnancy?
What is the chance my child will inherit ADPKD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my pre-pregnancy kidney function (serum creatinine), urine protein, and blood pressure, what is my individual risk level for pregnancy complications?
- 2.Which of my current medications (such as ACE inhibitors, ARBs, or tolvaptan) need to be stopped or switched before I stop using birth control, and what are the alternatives?
- 3.Am I a candidate for taking prescribed low-dose aspirin to help reduce my risk of pre-eclampsia, and when should I start?
- 4.How will we monitor my kidney function during pregnancy since standard eGFR calculations are not accurate when pregnant?
- 5.Can you refer me to a Maternal-Fetal Medicine (MFM) specialist and a reproductive genetic counselor for preconception planning?
- 6.Which blood pressure medications are safe to use while breastfeeding, and when can I resume ADPKD-specific treatments?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Pregnancy in Autosomal Dominant Polycystic Kidney Disease.
Al Sayyab M, Chapman A
Advances in kidney disease and health 2023; (30(5)):454-460 doi:10.1053/j.akdh.2023.10.006.
PMID: 38032583 - 2
Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A Narrative Review.
Sarmadian PJ, Pirooz AD, Al Baghdadi M, et al.
Journal of pregnancy 2026; (2026(1)):e9166037 doi:10.1155/jp/9166037.
PMID: 42473303 - 3
Predictors of autosomal dominant polycystic kidney disease progression: a Brazilian single-center cohort.
Nishimoto IH, Santos AG, Bianchini JM, et al.
Jornal brasileiro de nefrologia 2024; (46(3)):e20230040 doi:10.1590/2175-8239-JBN-2023-0040en.
PMID: 38935976 - 4
New insights in the pathophysiology and treatment of hypertension in autosomal dominant polycystic kidney disease.
Dumont A, Bellien J, Van Wynsberghe M, et al.
Kidney international 2025; (108(4)):592-608 doi:10.1016/j.kint.2025.05.036.
PMID: 40712885 - 5
Overview of ADPKD in Pregnancy.
Campbell RE, Edelstein CL, Chonchol M
Kidney international reports 2025; (10(4)):1011-1019 doi:10.1016/j.ekir.2024.12.035.
PMID: 40303224 - 6
Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges.
McBride L, Wilkinson C, Jesudason S
International journal of women's health 2020; (12()):409-422 doi:10.2147/IJWH.S204997.
PMID: 32547249 - 7
Pregnancy outcomes in autosomal dominant polycystic kidney disease: a case-control study.
Wu M, Wang D, Zand L, et al.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2016; (29(5)):807-12 doi:10.3109/14767058.2015.1019458.
PMID: 25754208 - 8
Considerations for genetic testing in individuals with autosomal dominant polycystic kidney disease.
Noce EM
Journal of the American Association of Nurse Practitioners 2022; (34(12)):1249-1251 doi:10.1097/JXX.0000000000000787.
PMID: 36469907 - 9
Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease.
Murphy EL, Droher ML, DiMaio MS, Dahl NK
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(6)):866-872 doi:10.1053/j.ajkd.2018.01.048.
PMID: 29606500 - 10
State of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies.
Thompson WS, Babayev SN, McGowan ML, et al.
Journal of the American Society of Nephrology : JASN 2024; (35(2)):235-248 doi:10.1681/ASN.0000000000000253.
PMID: 37882743 - 11
Preimplantation Genetic Testing for Kidney Disease-Related Genes: A Laboratory's Experience.
Chaperon JL, Wemmer NM, McKanna TA, et al.
American journal of nephrology 2021; (52(8)):684-690 doi:10.1159/000518253.
PMID: 34515037 - 12
Combined Preimplantation Genetic Testing for Autosomal Dominant Polycystic Kidney Disease: Consequences for Embryos Available for Transfer.
Mir Pardo P, Martínez-Conejero JA, Martín J, et al.
Genes 2020; (11(6)) doi:10.3390/genes11060692.
PMID: 32599795
This page is for informational purposes only and does not constitute medical advice. Your nephrologist and maternal-fetal medicine specialist should tailor medication changes, pregnancy monitoring, and family-planning decisions to your health.
Get notified when new evidence is published on Autosomal dominant polycystic kidney disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.